Agenda Topics- Advances in Enabling Discovery Technologies
- 3D Cell-based Assays
- Biologics
- High Content Assays
- High Content Flow Cytometry
- Label Free Screening Technologies
- Model Organisms e.g. C. elegans
- Patient Derived iPSC Cells
- Screening Stem Cells
- Target ID and Validation
- Natural Product Diversity & Novel Chemistries to Fill in the RnD Pipeline
- Addressing Emerging & Challenging Targets
- Assessing Natural Product Toxicities
- Bioassay Based Fractionation
- Natural Product Screening
- Novel Chemical Library Designs
- Repurposing Existing Approved Drugs
- Synthetic Biology for Complex Chemistries
Sponsorship and Exhibition OpportunitiesExhibition Team, exhibitors@selectbio.com +44 (0) 1206 501654
|
Confirmed Speakers to dateMark Butler, Senior Research Fellow, University of Queensland Charlie Chia, Senior Research Officer/Chief Scientist, Sarawak Biodiversity Centre Hakim Djaballah, CEO, Institute Pasteur - Korea Horst Flotow, Senior Project Manager, D3 (Drug Discovery and Development)e Mark Frattini, Associate Professor, Columbia University Medical Center Cedric Gaggioli, Baby Team Leader, Université Nice Sophia Antipolis Said Goueli, Clinical Professor & Research Fellow, Promega Corporation Jan Lichtenberg, CEO and Co-Founder, InSphero AG Stephen Pak, Assistant Professor, University of Pittsburgh School of Medicine Spencer Shorte, Director, Institut Pasteur Imagopole Gerardo Turcatti, Director, Ecole Polytechnique Federale De Lausanne Hui-Hui Wong, Lab Biologist, Frederic Bard Lab, Institute for Molecular and Cell Biology Lixin Zhang, Professor, Chinese Academy of Sciences
|